Menu
Search
|

Menu

Close
X

Tactile Systems Technology Inc TCMD.OQ (NASDAQ Stock Exchange Global Market)

30.88 USD
+0.95 (+3.17%)
As of 3:59 PM EST
chart
Previous Close 29.93
Open 30.12
Volume 62,951
3m Avg Volume 112,698
Today’s High 31.37
Today’s Low 30.12
52 Week High 37.80
52 Week Low 16.10
Shares Outstanding (mil) 17.70
Market Capitalization (mil) 529.81
Forward P/E 93.73
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.43 Mean rating from 7 analysts

KEY STATS

Revenue (mm, USD)
FY17
74
FY16
85
FY15
63
EPS (USD)
FY17
0.182
FY16
0.086
FY15
-0.027
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
93.73
35.64
Price to Sales (TTM)
vs sector
5.15
8.67
Price to Book (MRQ)
vs sector
7.72
5.21
Price to Cash Flow (TTM)
vs sector
73.58
26.03
Total Debt to Equity (MRQ)
vs sector
0.00
15.38
LT Debt to Equity (MRQ)
vs sector
0.00
12.01
Return on Investment (TTM)
vs sector
9.58
13.57
Return on Equity (TTM)
vs sector
9.64
15.19

EXECUTIVE LEADERSHIP

Peter Soderberg
Independent Chairman of the Board, Since 2012
Salary: --
Bonus: --
Gerald Mattys
Chief Executive Officer, Director, Since 2005
Salary: $390,192.00
Bonus: $339,467.00
Lynn Blake
Chief Financial Officer, Since 2016
Salary: $205,385.00
Bonus: $106,800.00
Robert Folkes
Chief Operating Officer, Since 2015
Salary: $260,077.00
Bonus: $137,841.00
Bryan Rishe
Vice President of Sales, Since 2008
Salary: $237,500.00
Bonus: $128,668.00

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1331 Tyler St NE Ste 200
MINNEAPOLIS   MN   55413-1638

Phone: +1612.3555100

Tactile Systems Technology, Inc. is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency. Its products deliver long-term treatment of chronic diseases. The Company provides its products for use in the home and sells them through vascular, wound and lymphedema clinics throughout the United States. The Company offers a platform to deliver at-home healthcare solutions throughout the United States. Its initial area of therapeutic focus is vascular disease, with a focus on advancing the care in treating lymphedema and chronic venous insufficiency.

SPONSORED STORIES